Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF

J.P. Ferreira*, J. Verdonschot, P. Wang, A. Pizard, T. Collier, F.Z. Ahmed, H.P. Brunner-La-Rocca, A.L. Clark, F. Cosmi, J. Cuthbert, J. Diez, F. Edelmann, N. Girerd, A. Gonzalez, S. Grojean, M. Hazebroek, J. Khan, R. Latini, M.A. Mamas, B. MariottoniB. Mujaj, P. Pellicori, J. Petutschnigg, B. Pieske, P. Rossignol, P. Rouet, J.A. Staessen, J.G.F. Cleland, S. Heymans, F. Zannad*, HOMAGE (Heart Omics in AGEing) Consortium

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Web of Science)
Original languageEnglish
Pages (from-to)268-277
Number of pages10
JournalJACC-Heart Failure
Issue number4
Publication statusPublished - 1 Apr 2021


  • fibrosis
  • heart failure prevention
  • inflammation
  • renin-angiotensin-aldosterone system
  • spironolactone

Cite this